{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:39:18Z","timestamp":1785343158729,"version":"3.55.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CTSC GRANT UL1-RR024996"],"award-info":[{"award-number":["CTSC GRANT UL1-RR024996"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM060665, RISE training Program"],"award-info":[{"award-number":["GM060665, RISE training Program"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MD007599"],"award-info":[{"award-number":["MD007599"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["0965983, IGERT Training Program"],"award-info":[{"award-number":["0965983, IGERT Training Program"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Neuroscience Collaborative Program, Graduate Center, CUNY","award":["none"],"award-info":[{"award-number":["none"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1305-3","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T09:46:36Z","timestamp":1537436796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Prostaglandin D2\/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets"],"prefix":"10.1186","volume":"15","author":[{"given":"Chuhyon","family":"Corwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Nikolopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen L.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela","family":"Nunez-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Vallabhajosula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Babich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5131-4315","authenticated-orcid":false,"given":"Maria E.","family":"Figueiredo-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,20]]},"reference":[{"key":"1305_CR1","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey MG, Goldberg MS. Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis. 2010;37:510\u20138.","journal-title":"Neurobiol Dis"},{"issue":"Suppl 1","key":"1305_CR2","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","volume":"18","author":"EC Hirsch","year":"2012","unstructured":"Hirsch EC, Vyas S, Hunot S. Neuroinflammation in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2012;18(Suppl 1):S210\u20132.","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 1","key":"1305_CR3","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1016\/S1353-8020(11)70064-5","volume":"18","author":"S Phani","year":"2012","unstructured":"Phani S, Loike JD, Przedborski S. Neurodegeneration and inflammation in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2012;18(Suppl 1):S207\u20139.","journal-title":"Parkinsonism Relat Disord"},{"key":"1305_CR4","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1007\/s00018-013-1352-y","volume":"70","author":"M Deleidi","year":"2013","unstructured":"Deleidi M, Gasser T. The role of inflammation in sporadic and familial Parkinson\u2019s disease. Cell Mol Life Sci. 2013;70:4259\u201373.","journal-title":"Cell Mol Life Sci"},{"key":"1305_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/7854_2014_356","volume":"22","author":"C Cebrian","year":"2015","unstructured":"Cebrian C, Loike JD, Sulzer D. Neuroinflammation in Parkinson\u2019s disease animal models: a cell stress response or a step in neurodegeneration? Curr Top Behav Neurosci. 2015;22:237\u201370.","journal-title":"Curr Top Behav Neurosci"},{"key":"1305_CR6","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1073\/pnas.0837397100","volume":"100","author":"P Teismann","year":"2003","unstructured":"Teismann P, Tieu K, Choi DK, Wu DC, Naini A, Hunot S, et al. Cyclooxygenase-2 is instrumental in Parkinson\u2019s disease neurodegeneration. Proc Natl Acad Sci U S A. 2003;100:5473\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1305_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12031-007-0058-8","volume":"33","author":"X Liang","year":"2007","unstructured":"Liang X, Wu L, Wang Q, Hand T, Bilak M, McCullough L, et al. Function of COX-2 and prostaglandins in neurological disease. J Mol Neurosci. 2007;33:94\u20139.","journal-title":"J Mol Neurosci"},{"key":"1305_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2174\/157015910790909485","volume":"8","author":"AL Bartels","year":"2010","unstructured":"Bartels AL, Leenders KL. Cyclooxygenase and neuroinflammation in Parkinson\u2019s disease neurodegeneration. Curr Neuropharmacol. 2010;8:62\u20138.","journal-title":"Curr Neuropharmacol"},{"key":"1305_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.expneurol.2013.05.014","volume":"256","author":"CP Ramsey","year":"2014","unstructured":"Ramsey CP, Tansey MG. A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson\u2019s disease and potential molecular targets. Exp Neurol. 2014;256:126\u201332.","journal-title":"Exp Neurol"},{"key":"1305_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1742-2094-6-18","volume":"6","author":"SR Pierre","year":"2009","unstructured":"Pierre SR, Lemmens MA, Figueiredo-Pereira ME. Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice. J Neuroinflammation. 2009;6:18.","journal-title":"J Neuroinflammation"},{"key":"1305_CR11","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.bbadis.2014.06.020","volume":"1842","author":"KY Shivers","year":"2014","unstructured":"Shivers KY, Nikolopoulou A, Machlovi SI, Vallabhajosula S, Figueiredo-Pereira ME. PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2. Biochim Biophys Acta. 2014;1842:1707\u201319.","journal-title":"Biochim Biophys Acta"},{"key":"1305_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1471-4159.1984.tb06680.x","volume":"43","author":"T Ogorochi","year":"1984","unstructured":"Ogorochi T, Narumiya S, Mizuno N, Yamashita K, Miyazaki H, Hayaishi O. Regional distribution of prostaglandins D2, E2, and F2 alpha and related enzymes in postmortem human brain. J Neurochem. 1984;43:71\u201382.","journal-title":"J Neurochem"},{"key":"1305_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1749-6632.1989.tb22600.x","volume":"559","author":"G Hertting","year":"1989","unstructured":"Hertting G, Seregi A. Formation and function of eicosanoids in the central nervous system. Ann N Y Acad Sci. 1989;559:84\u201399.","journal-title":"Ann N Y Acad Sci"},{"key":"1305_CR14","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"E Ricciotti","year":"2011","unstructured":"Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31:986\u20131000.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1305_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jchromb.2013.11.041","volume":"945-946","author":"JS Shaik","year":"2014","unstructured":"Shaik JS, Miller TM, Graham SH, Manole MD, Poloyac SM. Rapid and simultaneous quantitation of prostanoids by UPLC-MS\/MS in rat brain. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;945-946:207\u201316.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1305_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1471-4159.2004.02870.x","volume":"92","author":"X Liang","year":"2005","unstructured":"Liang X, Wu L, Hand T, Andreasson K. Prostaglandin D2 mediates neuronal protection via the DP1 receptor. J Neurochem. 2005;92:477\u201386.","journal-title":"J Neurochem"},{"key":"1305_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuro.2013.08.001","volume":"39","author":"H Liu","year":"2013","unstructured":"Liu H, Li W, Rose ME, Pascoe JL, Miller TM, Ahmad M, et al. Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites. Neurotoxicology. 2013;39:35\u201344.","journal-title":"Neurotoxicology"},{"key":"1305_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1021\/tx700177j","volume":"21","author":"K Uchida","year":"2008","unstructured":"Uchida K, Shibata T. 15-Deoxy-D(12,14)-prostaglandin J2: an electrophilic trigger of cellular responses. Chem Res Toxicol. 2008;21:138\u201344.","journal-title":"Chem Res Toxicol"},{"key":"1305_CR19","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.bbrc.2004.05.098","volume":"319","author":"Z Li","year":"2004","unstructured":"Li Z, Melandri F, Berdo I, Jansen M, Hunter L, Wright S, et al. D12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition. Biochem Biophys Res Commun. 2004;319:1171\u201380.","journal-title":"Biochem Biophys Res Commun"},{"key":"1305_CR20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0022-3565(25)23605-9","volume":"239","author":"S Narumiya","year":"1986","unstructured":"Narumiya S, Fukushima M. Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. J Pharmacol Exp Ther. 1986;239:500\u20135.","journal-title":"J Pharmacol Exp Ther"},{"key":"1305_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1517\/13543784.2015.963195","volume":"24","author":"AR Carta","year":"2015","unstructured":"Carta AR, Simuni T. Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson\u2019s disease. Expert Opin Investig Drugs. 2015;24:219\u201327.","journal-title":"Expert Opin Investig Drugs"},{"key":"1305_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1203\/PDR.0b013e3180db2902","volume":"62","author":"RW Hickey","year":"2007","unstructured":"Hickey RW, Adelson PD, Johnnides MJ, Davis DS, Yu Z, Rose ME, et al. Cyclooxygenase-2 activity following traumatic brain injury in the developing rat. Pediatr Res. 2007;62:271\u20136.","journal-title":"Pediatr Res"},{"key":"1305_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.parkreldis.2009.06.005","volume":"16","author":"C Becker","year":"2010","unstructured":"Becker C, Jick SS, Meier CR. Risk of stroke in patients with idiopathic Parkinson disease. Parkinsonism Relat Disord. 2010;16:31\u20135.","journal-title":"Parkinsonism Relat Disord"},{"key":"1305_CR24","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1089\/neu.2010.1723","volume":"28","author":"CB Hutson","year":"2011","unstructured":"Hutson CB, Lazo CR, Mortazavi F, Giza CC, Hovda D, Chesselet MF. Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat. J Neurotrauma. 2011;28:1783\u2013801.","journal-title":"J Neurotrauma"},{"key":"1305_CR25","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jnr.20346","volume":"78","author":"Z Li","year":"2004","unstructured":"Li Z, Jansen M, Ogburn K, Salvatierra L, Hunter L, Mathew S, et al. Neurotoxic prostaglandin J2 enhances cyclooxygenase-2 expression in neuronal cells through the p38MAPK pathway: a death wish? J Neurosci Res. 2004;78:824\u201336.","journal-title":"J Neurosci Res"},{"key":"1305_CR26","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1212\/WNL.0b013e31820f2d79","volume":"76","author":"X Gao","year":"2011","unstructured":"Gao X, Chen H, Schwarzschild MA, Ascherio A. Use of ibuprofen and risk of Parkinson disease. Neurology. 2011;76:863\u20139.","journal-title":"Neurology"},{"key":"1305_CR27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/9781118743614.ch14","volume-title":"Ibuprofen: discovery, developmeny and therapeutics","author":"KD Rainsford","year":"2015","unstructured":"Rainsford KD. Ibuprofen in prevention of neurodegenerative diseases. In: Rainsford KD, editor. Ibuprofen: discovery, developmeny and therapeutics. Hoboken: Wiley; 2015. p. 547\u201370."},{"key":"1305_CR28","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1172\/JCI58656","volume":"122","author":"E Czirr","year":"2012","unstructured":"Czirr E, Wyss-Coray T. The immunology of neurodegeneration. J Clin Invest. 2012;122:1156\u201363.","journal-title":"J Clin Invest"},{"key":"1305_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1242\/dmm.002733","volume":"2","author":"PM Iannaccone","year":"2009","unstructured":"Iannaccone PM, Jacob HJ. Rats! Dis Model Mech. 2009;2:206\u201310.","journal-title":"Dis Model Mech"},{"key":"1305_CR30","first-page":"1","volume":"16634","author":"J Phillips","year":"2013","unstructured":"Phillips J, Hogan A. Animals in research: rats. Conversation. 2013;16634:1\u20134.","journal-title":"Conversation"},{"key":"1305_CR31","unstructured":"Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 7th ed. Cambridge: Academic Press; 2013."},{"key":"1305_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-8993(02)03006-8","volume":"954","author":"RL Richardson","year":"2002","unstructured":"Richardson RL, Kim EM, Shephard RA, Gardiner T, Cleary J, O'Hare E. Behavioural and histopathological analyses of ibuprofen treatment on the effect of aggregated Abeta(1-42) injections in the rat. Brain Res. 2002;954:1\u201310.","journal-title":"Brain Res"},{"key":"1305_CR33","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.tips.2005.05.002","volume":"26","author":"NB Mercuri","year":"2005","unstructured":"Mercuri NB, Bernardi G. The \u2018magic\u2019 of L-dopa: why is it the gold standard Parkinson\u2019s disease therapy? Trends Pharmacol Sci. 2005;26:341\u20134.","journal-title":"Trends Pharmacol Sci"},{"key":"1305_CR34","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","volume":"39","author":"T Schallert","year":"2000","unstructured":"Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology. 2000;39:777\u201387.","journal-title":"Neuropharmacology"},{"key":"1305_CR35","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1523\/JNEUROSCI.21-12-04427.2001","volume":"21","author":"JL Tillerson","year":"2001","unstructured":"Tillerson JL, Cohen AD, Philhower J, Miller GW, Zigmond MJ, Schallert T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci. 2001;21:4427\u201335.","journal-title":"J Neurosci"},{"key":"1305_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fnsys.2014.00110","volume":"8","author":"I Molochnikov","year":"2014","unstructured":"Molochnikov I, Cohen D. Hemispheric differences in the mesostriatal dopaminergic system. Front Syst Neurosci. 2014;8:110.","journal-title":"Front Syst Neurosci"},{"key":"1305_CR37","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/j.1749-6632.1965.tb11715.x","volume":"128","author":"JM Prewitt","year":"1966","unstructured":"Prewitt JM, Mendelsohn ML. The analysis of cell images. Ann N Y Acad Sci. 1966;128:1035\u201353.","journal-title":"Ann N Y Acad Sci"},{"key":"1305_CR38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/CH-2012-1610","volume":"52","author":"S Braune","year":"2012","unstructured":"Braune S, Alagoz G, Seifert B, Lendlein A, Jung F. Automated image-based analysis of adherent thrombocytes on polymer surfaces. Clin Hemorheol Microcirc. 2012;52:349\u201355.","journal-title":"Clin Hemorheol Microcirc"},{"key":"1305_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fncel.2013.00003","volume":"7","author":"A Karperien","year":"2013","unstructured":"Karperien A, Ahammer H, Jelinek HF. Quantitating the subtleties of microglial morphology with fractal analysis. Front Cell Neurosci. 2013;7:3.","journal-title":"Front Cell Neurosci"},{"key":"1305_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9","volume":"63","author":"Z Soltys","year":"2001","unstructured":"Soltys Z, Ziaja M, Pawlinski R, Setkowicz Z, Janeczko K. Morphology of reactive microglia in the injured cerebral cortex. Fractal analysis and complementary quantitative methods. J Neurosci Res. 2001;63:90\u20137.","journal-title":"J Neurosci Res"},{"key":"1305_CR41","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.neuroscience.2009.04.031","volume":"161","author":"ZC Baquet","year":"2009","unstructured":"Baquet ZC, Williams D, Brody J, Smeyne RJ. A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL\/6J mouse. Neuroscience. 2009;161:1082\u201390.","journal-title":"Neuroscience"},{"key":"1305_CR42","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3","volume":"369","author":"EL Nelson","year":"1996","unstructured":"Nelson EL, Liang CL, Sinton CM, German DC. Midbrain dopaminergic neurons in the mouse: computer-assisted mapping. J Comp Neurol. 1996;369:361\u201371.","journal-title":"J Comp Neurol"},{"key":"1305_CR43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0022-510X(71)90178-X","volume":"14","author":"S Fahn","year":"1971","unstructured":"Fahn S, Libsch LR, Cutler RW. Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor. J Neurol Sci. 1971;14:427\u201355.","journal-title":"J Neurol Sci"},{"key":"1305_CR44","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973;20:415\u201355.","journal-title":"J Neurol Sci"},{"key":"1305_CR45","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"E Hirsch","year":"1988","unstructured":"Hirsch E, Graybiel AM, Agid YA. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease. Nature. 1988;334:345\u20138.","journal-title":"Nature"},{"key":"1305_CR46","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/mds.21010","volume":"21","author":"GE Meredith","year":"2006","unstructured":"Meredith GE, Kang UJ. Behavioral models of Parkinson's disease in rodents: a new look at an old problem. Mov Disord. 2006;21:1595\u2013606.","journal-title":"Mov Disord"},{"key":"1305_CR47","first-page":"278","volume":"9","author":"HL Ben","year":"2015","unstructured":"Ben HL, Carrillo-de Sauvage MA, Ceyzeriat K, Escartin C. Elusive roles for reactive astrocytes in neurodegenerative diseases. Front Cell Neurosci. 2015;9:278.","journal-title":"Front Cell Neurosci"},{"key":"1305_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00401-012-1004-6","volume":"124","author":"D Ebrahimi-Fakhari","year":"2012","unstructured":"Ebrahimi-Fakhari D, Wahlster L, McLean PJ. Protein degradation pathways in Parkinson's disease: curse or blessing. Acta Neuropathol. 2012;124:153\u201372.","journal-title":"Acta Neuropathol"},{"key":"1305_CR49","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0166-2236(98)01276-4","volume":"21","author":"A Alves-Rodrigues","year":"1998","unstructured":"Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 1998;21:516\u201320.","journal-title":"Trends Neurosci"},{"issue":"1","key":"1305_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3233\/JPD-160779","volume":"6","author":"Abid Oueslati","year":"2016","unstructured":"Oueslati A. Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade? J Park Dis. 2016;6(1):39\u201351.","journal-title":"Journal of Parkinson's Disease"},{"key":"1305_CR51","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.expneurol.2007.02.008","volume":"205","author":"E Esposito","year":"2007","unstructured":"Esposito E, Di MV, Benigno A, Pierucci M, Crescimanno G, Di GG. Non-steroidal anti-inflammatory drugs in Parkinson\u2019s disease. Exp Neurol. 2007;205:295\u2013312.","journal-title":"Exp Neurol"},{"key":"1305_CR52","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/mds.21751","volume":"23","author":"PL McGeer","year":"2008","unstructured":"McGeer PL, McGeer EG. Glial reactions in Parkinson\u2019s disease. Mov Disord. 2008;23:474\u201383.","journal-title":"Mov Disord"},{"key":"1305_CR53","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.4049\/jimmunol.168.7.3563","volume":"168","author":"G Monneret","year":"2002","unstructured":"Monneret G, Li H, Vasilescu J, Rokach J, Powell WS. 15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils. J Immunol. 2002;168:3563\u20139.","journal-title":"J Immunol"},{"key":"1305_CR54","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrd2266","volume":"6","author":"R Pettipher","year":"2007","unstructured":"Pettipher R, Hansel TT, Armer R. Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. Nat Rev Drug Discov. 2007;6:313\u201325.","journal-title":"Nat Rev Drug Discov"},{"key":"1305_CR55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fneur.2012.00145","volume":"3","author":"S Mohan","year":"2012","unstructured":"Mohan S, Ahmad AS, Glushakov AV, Chambers C, Dore S. Putative role of prostaglandin receptor in intracerebral hemorrhage. Front Neurol. 2012;3:145.","journal-title":"Front Neurol"},{"key":"1305_CR56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.pharmthera.2004.06.003","volume":"103","author":"AN Hata","year":"2004","unstructured":"Hata AN, Breyer RM. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther. 2004;103:147\u201366.","journal-title":"Pharmacol Ther"},{"key":"1305_CR57","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/glia.22487","volume":"61","author":"H Kanda","year":"2013","unstructured":"Kanda H, Kobayashi K, Yamanaka H, Noguchi K. COX-1-dependent prostaglandin D2 in microglia contributes to neuropathic pain via DP2 receptor in spinal neurons. Glia. 2013;61:943\u201356.","journal-title":"Glia"},{"key":"1305_CR58","doi-asserted-by":"publisher","first-page":"24646","DOI":"10.1038\/srep24646","volume":"6","author":"J Ma","year":"2016","unstructured":"Ma J, Yang Q, Wei Y, Yang Y, Ji C, Hu X, et al. Effect of the PGD2-DP signaling pathway on primary cultured rat hippocampal neuron injury caused by aluminum overload. Sci Rep. 2016;6:24646.","journal-title":"Sci Rep"},{"key":"1305_CR59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4161\/pri.23582","volume":"7","author":"DJ Surmeier","year":"2013","unstructured":"Surmeier DJ, Sulzer D. The pathology roadmap in Parkinson disease. Prion. 2013;7:85\u201391.","journal-title":"Prion"},{"key":"1305_CR60","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0167-4838(00)00161-8","volume":"1482","author":"Y Urade","year":"2000","unstructured":"Urade Y, Hayaishi O. Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim Biophys Acta. 2000;1482:259\u201371.","journal-title":"Biochim Biophys Acta"},{"key":"1305_CR61","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0167-4838(00)00163-1","volume":"1482","author":"S Xu","year":"2000","unstructured":"Xu S, Venge P. Lipocalins as biochemical markers of disease. Biochim Biophys Acta. 2000;1482:298\u2013307.","journal-title":"Biochim Biophys Acta"},{"key":"1305_CR62","first-page":"166","volume":"2","author":"JK Maesaka","year":"2013","unstructured":"Maesaka JK, Sodam B, Palaia T, Ragolia L, Batuman V, Miyawaki N, et al. Prostaglandin D2 synthase: apoptotic factor in alzheimer plasma, inducer of reactive oxygen species, inflammatory cytokines and dialysis dementia. J Nephropathol. 2013;2:166\u201380.","journal-title":"J Nephropathol"},{"key":"1305_CR63","doi-asserted-by":"publisher","first-page":"9414","DOI":"10.1074\/jbc.M111.330662","volume":"287","author":"S Lee","year":"2012","unstructured":"Lee S, Jang E, Kim JH, Kim JH, Lee WH, Suk K. Lipocalin-type prostaglandin D2 synthase protein regulates glial cell migration and morphology through myristoylated alanine-rich C-kinase substrate: prostaglandin D2-independent effects. J Biol Chem. 2012;287:9414\u201328.","journal-title":"J Biol Chem"},{"key":"1305_CR64","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4161\/cam.20251","volume":"6","author":"K Suk","year":"2012","unstructured":"Suk K. Unexpected role of lipocalin-type prostaglandin D synthase in brain: regulation of glial cell migration and morphology. Cell Adhes Migr. 2012;6:160\u20133.","journal-title":"Cell Adhes Migr"},{"key":"1305_CR65","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1155\/2006\/241817","volume":"22","author":"MG Harrington","year":"2006","unstructured":"Harrington MG, Fonteh AN, Biringer RG, AF RH, Cowan RP. Prostaglandin D synthase isoforms from cerebrospinal fluid vary with brain pathology. Dis Markers. 2006;22:73\u201381.","journal-title":"Dis Markers"},{"key":"1305_CR66","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.clim.2004.09.008","volume":"114","author":"JU Scher","year":"2005","unstructured":"Scher JU, Pillinger MH. 15d-PGJ2: the anti-inflammatory prostaglandin? Clin Immunol. 2005;114:100\u20139.","journal-title":"Clin Immunol"},{"key":"1305_CR67","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0090-6980(02)00050-3","volume":"68-69","author":"HH Tai","year":"2002","unstructured":"Tai HH, Ensor CM, Tong M, Zhou H, Yan F. Prostaglandin catabolizing enzymes. Prostaglandins Other Lipid Mediat. 2002;68-69:483\u201393.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"1305_CR68","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1742-2094-7-25","volume":"7","author":"NG Carlson","year":"2010","unstructured":"Carlson NG, Rojas MA, Redd JW, Tang P, Wood B, Hill KE, et al. Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death. J Neuroinflammation. 2010;7:25.","journal-title":"J Neuroinflammation"},{"key":"1305_CR69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/alzrt171","volume":"5","author":"L Lecanu","year":"2013","unstructured":"Lecanu L, Papadopoulos V. Modeling Alzheimer\u2019s disease with non-transgenic rat models. Alzheimers Res Ther. 2013;5:17.","journal-title":"Alzheimers Res Ther"},{"key":"1305_CR70","doi-asserted-by":"publisher","unstructured":"Rees K, Stowe R, Patel S, Ives N, Breen K, Clarke CE, et al. Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies. Cochrane Database Syst Rev. 2011:CD008454. https:\/\/doi.org\/10.1002\/14651858.CD008454.pub2 .","DOI":"10.1002\/14651858.CD008454.pub2"},{"key":"1305_CR71","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.neurol.2015.07.011","volume":"171","author":"P Gubellini","year":"2015","unstructured":"Gubellini P, Kachidian P. Animal models of Parkinson\u2019s disease: an updated overview. Rev Neurol (Paris). 2015;171:750\u201361.","journal-title":"Rev Neurol (Paris)"},{"key":"1305_CR72","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1460-9568.2005.04220.x","volume":"22","author":"MM Iravani","year":"2005","unstructured":"Iravani MM, Leung CC, Sadeghian M, Haddon CO, Rose S, Jenner P. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation. Eur J Neurosci. 2005;22:317\u201330.","journal-title":"Eur J Neurosci"},{"key":"1305_CR73","first-page":"327089","volume":"2011","author":"M Liu","year":"2011","unstructured":"Liu M, Bing G. Lipopolysaccharide animal models for Parkinson\u2019s disease. Park Dis. 2011;2011:327089.","journal-title":"Park Dis"},{"key":"1305_CR74","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.20467","volume":"55","author":"L Qin","year":"2007","unstructured":"Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55:453\u201362.","journal-title":"Glia"},{"key":"1305_CR75","doi-asserted-by":"publisher","first-page":"845618","DOI":"10.1155\/2012\/845618","volume":"2012","author":"J Blesa","year":"2012","unstructured":"Blesa J, Phani S, Jackson-Lewis V, Przedborski S. Classic and new animal models of Parkinson\u2019s disease. J Biomed Biotechnol. 2012;2012:845618.","journal-title":"J Biomed Biotechnol"},{"key":"1305_CR76","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fnana.2014.00155","volume":"8","author":"J Blesa","year":"2014","unstructured":"Blesa J, Przedborski S. Parkinson's disease: animal models and dopaminergic cell vulnerability. Front Neuroanat. 2014;8:155.","journal-title":"Front Neuroanat"},{"key":"1305_CR77","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mds.23455","volume":"26","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Stevens CH. Glia: initiators and progressors of pathology in Parkinson\u2019s disease. Mov Disord. 2011;26:6\u201317.","journal-title":"Mov Disord"},{"key":"1305_CR78","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2014.10.028","volume":"302","author":"N Dzamko","year":"2015","unstructured":"Dzamko N, Geczy CL, Halliday GM. Inflammation is genetically implicated in Parkinson's disease. Neuroscience. 2015;302:89\u2013102.","journal-title":"Neuroscience"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1305-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1305-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1305-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:51:38Z","timestamp":1751935898000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1305-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,20]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1305"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1305-3","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,20]]},"assertion":[{"value":"16 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our study followed the strict recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (NIH). Our protocol was approved by the Hunter College, CUNY Institutional Animal Care and Use Committee. Surgeries were carried out under isoflurane anesthesia, and we made all efforts to minimize animal suffering.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"272"}}